ATE414282T1 - Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum - Google Patents

Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum

Info

Publication number
ATE414282T1
ATE414282T1 AT03793839T AT03793839T ATE414282T1 AT E414282 T1 ATE414282 T1 AT E414282T1 AT 03793839 T AT03793839 T AT 03793839T AT 03793839 T AT03793839 T AT 03793839T AT E414282 T1 ATE414282 T1 AT E414282T1
Authority
AT
Austria
Prior art keywords
value
marker
individual
cut
pepsinogen
Prior art date
Application number
AT03793839T
Other languages
English (en)
Inventor
Osmo Suovaniemi
Matti Haerkoenen
Pentti Sipponen
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Application granted granted Critical
Publication of ATE414282T1 publication Critical patent/ATE414282T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03793839T 2002-09-06 2003-09-05 Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum ATE414282T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20021598A FI119571B (fi) 2002-09-06 2002-09-06 Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä

Publications (1)

Publication Number Publication Date
ATE414282T1 true ATE414282T1 (de) 2008-11-15

Family

ID=8564544

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03793839T ATE414282T1 (de) 2002-09-06 2003-09-05 Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum

Country Status (10)

Country Link
EP (1) EP1552311B1 (de)
JP (1) JP4261481B2 (de)
KR (1) KR101108282B1 (de)
CN (1) CN1682115A (de)
AT (1) ATE414282T1 (de)
AU (1) AU2003260530A1 (de)
DE (1) DE60324698D1 (de)
EA (1) EA007003B1 (de)
FI (1) FI119571B (de)
WO (1) WO2004023148A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508838A (ja) 2001-03-23 2005-04-07 アフトン コーポレーション 膵癌の組合せ治療
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
US7235376B2 (en) 2003-03-28 2007-06-26 Receptor Biologix, Inc. Gastrin hormone immunoassays
FI119572B (fi) * 2004-03-05 2008-12-31 Biohit Oyj Menetelmä vatsan limakalvon tilan ennustamiseksi
EP1794586B1 (de) 2004-09-22 2013-01-30 Cancer Advances, Inc., Monoklonale antikörper gegen progastrin
FI20060501L (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi vatsassa
WO2011161301A1 (en) * 2010-06-24 2011-12-29 Valtion Teknillinen Tutkimuskeskus State inference in a heterogeneous system
CN113514647A (zh) * 2014-06-13 2021-10-19 拜奥希特公司 胃泌素-17作为具有增加的数种相关后发病风险的萎缩性胃炎的生物标志物的用途
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法
KR102637908B1 (ko) * 2018-12-28 2024-02-20 씨제이제일제당 (주) 헬리코박터 파일로리 연관 질환에 대한 유전자 마커

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI118653B (fi) * 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi

Also Published As

Publication number Publication date
EA200500449A1 (ru) 2005-08-25
DE60324698D1 (de) 2008-12-24
KR20050057220A (ko) 2005-06-16
JP4261481B2 (ja) 2009-04-30
WO2004023148A1 (en) 2004-03-18
EP1552311B1 (de) 2008-11-12
FI119571B (fi) 2008-12-31
FI20021598A0 (fi) 2002-09-06
AU2003260530A1 (en) 2004-03-29
EA007003B1 (ru) 2006-06-30
KR101108282B1 (ko) 2012-01-31
EP1552311A1 (de) 2005-07-13
FI20021598A (fi) 2004-03-07
CN1682115A (zh) 2005-10-12
JP2005538348A (ja) 2005-12-15

Similar Documents

Publication Publication Date Title
WO2002054084A8 (en) A method for diagnosing atrophic gastritis
PT1776587E (pt) Utilização de c3a e seus derivados como biomarcador para o adenoma e/ou carcinoma colorrectal; processos de diagnóstico e ensaios utilizando os mesmos
ATE230801T1 (de) Verfahren zur detektion von zielnukleinsäure, verfahren zu ihrer quantifizierung und pyrylium- verbindungen zur chemilumineszenz-analyse
WO2006126008A3 (en) Improved immunoassay methods
ATE508360T1 (de) Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde
NO20061498L (no) Fremgangsmate for bestemmelse av inneholdet av minst en gitt gass i en boreslam
DE60213730D1 (de) Echtzeit-Quantifizierung mit internen Standards
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
ATE436015T1 (de) Verfahren, chip, vorrichtung und integriertes system zum nachweis biologischer partikel
ATE414282T1 (de) Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum
DE60021369D1 (de) Verfahren zur abschätzung eines magengeschwür-risikos
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE60333876D1 (de) Methoden zum Nachweis Analyten in Proben
ATE430938T1 (de) Verfahren zur vorhersage des zustands der magenschleimhaut
DE60307337D1 (de) Verfahren zur Identifizierung von Umweltkontaminationen durch Detektion von Enteroviren
WO2002077645A3 (en) Method for the measurement of soluble analytes
ATE495267T1 (de) Diagnostisches verfahren zum nachweis von helicobacter pylori
ATE344839T1 (de) Verfahren zum nachweis von arsenionen durch indikatorbakterien
DE50115503D1 (de) Verfahren und mittel zur bestimmung von gesamthärte
DK0677589T3 (da) Fremgangsmåde, testelement og testkit til semikvntitativ påvisning af mål-nucleinsyre
GB0304832D0 (en) Assay method
ATE517344T1 (de) Verfahren zum nachweis des immunisierungszustands einer person
DE60317497D1 (de) Verfahren, system und kit zum nachweis eines analyten in einer probe
TH49514A (th) วิธีการและอุปกรณ์สำหรับการตรวจจับการมีอยู่ของของไหลบนแผ่นแถบทดสอบ

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties